A215- Urinary bladder cancer tissues

Size: px
Start display at page:

Download "A215- Urinary bladder cancer tissues"

Transcription

1 A215- Urinary bladder cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Urinary bladder cancer tissues No. of spots: 2 spots from each cancer case (90 spots) Total spots: 94 4 non-neoplastic spots (4 spots) Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm Documents: Product specification: layout, summary of tissue spots H&E stained images Detailed pathological information Layout: A B C D E F G H I : Urothelial : Urothelial in situ : Adeno + other pathology : Squamous : Non-neoplastic

2 A215- Urinary bladder cancer tissues Summary of tissue spots (formalin fixed) For research use only No Coordinate Sex Age Key Word TNM Stage 1 1,2 m 64 Urothelial 2 3,4 m 49 Urothelial TaN0M0 ( 0a ) 3 5,6 m 56 Urothelial T1aN0M0 ( Ⅰ ) 4 A 7,8 m 41 Urothelial TaN0M0 ( 0a ) 5 9,10 m 48 Adeno signet ring cell T3aN0M0 ( Ⅲ ) 6 11 m 48 Non-neoplastic from A9,10 7 1,2 f 77 Papillary Urothelial 8 3,4 m 68 Urothelial TaN0M0 ( 0a ) 9 5,6 f 44 Urothelial T1aN0M0 ( Ⅰ ) 10 B 7,8 m 55 Urothelial T1aN0M0 ( Ⅰ ) 11 9,10 m 53 Transitional cell Adeno m 48 Non-neoplastic from A9, , 2 m 72 Urothelial T4aN0M0 ( Ⅲ ) 14 3, 4 m 63 Papillary Urothelial 15 5, 6 m 51 Urothelial TaN0M0 ( 0a ) 16 C Papillary 7, 8 m 75 Urothelial TaN0M0 ( 0a ) 17 9, 10 f 33 Adeno Mucinous adeno T3N0M0 ( Ⅲ ) f 33 Non-neoplastic from C9, , 2 m 60 Urothelial 20 3, 4 m 65 Urothelial T4aN0M0 ( Ⅲ ) 21 5, 6 m 68 Urothelial TaN0M0 ( 0a ) D 22 7, 8 m 58 Urothelial T1aN0M0 ( Ⅰ ) 23 9, 10 m 44 Adeno f 33 Non-neoplastic from C9, , 2 m 66 Urothelial T4aN0M0 ( Ⅲ ) 26 3, 4 f 74 Urothelial T1aN0M0 ( Ⅰ ) 27 5, 6 m 81 Urothelial T2N0M0 ( Ⅱ ) 28 E 7, 8 f 58 Urothelial T3bN1M0 ( Ⅳ ) 29 9, 10 m 44 Mucinous adeno Adeno Urachal adeno

3 A215- Urinary bladder cancer tissues Summary of tissue spots (formalin fixed) For research use only No Coordinate Sex Age Key Word TNM Stage 30 1, 2 f 79 Urothelial T2N0M0 ( Ⅱ ) 31 3, 4 f 75 Urothelial T1bN0M0 ( Ⅰ ) 32 F 5, 6 m 67 Urothelial T3bN0M0 ( Ⅲ ) 33 7, 8 m 67 Urothelial T3bN0M0 ( Ⅲ ) 34 9, 10 m 86 Squamous cell 35 1, 2 m 62 Urothelial T4aN0M1 ( Ⅳ ) 36 3, 4 m 86 Urothelial T4N1M1 ( Ⅳ ) 37 5, 6 m 76 Urothelial T2bN0M0 ( Ⅱ ) G 38 7, 8 m 64 Urothelial T1bN0M0 ( Ⅰ ) 39 9, 10 f 69 Urothelial Squamous cell T1bN0M0 ( Ⅰ ) 40 1, 2 m 67 Urothelial T2aN0M0 ( Ⅱ ) 41 3, 4 m 75 Urothelial T3bN0M0 ( Ⅲ ) 42 H 5, 6 f 66 Urothelial 43 7, 8 f 72 Urothelial T1aN0M0 ( Ⅰ ) 44 9, 10 f 59 Squamous cell T2bN0M0 ( Ⅱ ) 45 1, 2 m 87 Urothelial T2N0M0 ( Ⅱ ) 46 3, 4 m 52 Urothelial Carcinoma in situ TisN0M0 (0is ) 47 I 5, 6 f 59 Urothelial Carcinoma in situ TisN0M0 (0is ) 48 7, 8 m 64 Urothelial Carcinoma in situ TisN0M0 (0is ) 49 9, 10 m Squamous cell T2N0M0 ( Ⅱ )

4 A215- Urinary bladder cancer tissues (formalin fixed) For research use only QC sheet_lot# Hematoxylin and Eosin staining A1 A2 A3 A4 A5 A6 A7 A8 A9 A10 A11 B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 C1 C2

5 A215- Urinary bladder cancer tissues (formalin fixed) For research use only QC sheet_lot# Hematoxylin and Eosin staining C3 C4 C5 C6 C7 C8 C9 C10 C11 D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 D11 E1 E2 E3 E4

6 A215- Urinary bladder cancer tissues (formalin fixed) For research use only QC sheet_lot# Hematoxylin and Eosin staining E5 E6 E7 E8 E9 E10 F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 G1 G2 G3 G4 G5 G6 G7 G8

7 A215- Urinary bladder cancer tissues (formalin fixed) For research use only QC sheet_lot# Hematoxylin and Eosin staining G9 G10 H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 I1 I2 I3 I4 I5 I6 I7 I8 I9 I10

8 Urinary bladder, main mass, TURBT: low-grade papillary 1 A 1,2 m 64 Urinary bladder, deep biopsy: muscularis propria is free of neoplastic involvement Urinary bladder, dome, right lateral and left lateral wall, biopsy: free of tumor. 2 A 3,4 m 49 3 A 5,6 m 56 4 A 7,8 m 41 Urinary bladder, main mass, TURBT: low-grade papillary. Urinary bladder, deep, dome, right and left lateral wall, biopsy: free of tumor. Urinary bladder, TURBT: 1) right posterior wall: papillary, low grade, without stromal invasion 2) left bladder neck mass and deep biopsy and anterior wall mass: papillary, high grade, with superficial stromal invasion(pt1a). Urinary bladder, biopsy: 1) main mass and deep biopsy: papillary, low grade, without lamina propria invasion 2) posterior wall and right and left lateral walls: free of tumor. TaN0M0 ( 0a ) T1aN0M0 ( Ⅰ ) TaN0M0 ( 0a ) 5 A 9,10 m 48 adeno signet ring cell 6 A 11 m 48 non-neoplastic Non-neoplastic from A9,10 1.Urinary bladder, partial cystectomy: 1) adeno, with extensive mucin production and signet ring cell feature invading perivascular fat tissue. 2) resection margin: free of tumor, see note. 2. Skin, abdominal wall: free of tumor. Note: mucosal margins of urinary bladder are free of tumor. The tumor deeply extends beyond the deep muscle layer and is covered by peritoneum, which is involved, but not penetrated by neoplasm. T3aN0M0 ( Ⅲ )

9 7 B 1,2 f 77 8 B 3,4 m 68 9 B 5,6 f B 7,8 m B 9,10 m 53 papillary transitional cell adeno 12 B 11 m 48 non-neoplastic Non-neoplastic from A9,10 Urinary bladder, TURBT: 1) main mass(right dome): papillary, high grade (transitional cell, grade II) 2) deep biopsy: free of tumor 3) dome, right: papillary, high grade 4) posterior wall: papillary, high grade, with superficial laminar invasion 5) dome, right lateral and left lateral: free of tumor. 1) main mass: papillary, high grade (transitional cell grade 2) without stromal invasion (pta) 2) tumor bed: free of tumor 3) deep biopsy: free of tumor. 1) main mass dome, dome mass, bladder neck, bladder neck deep biopsy: papillary, high grade (transitional cell, grade II), with focally superficial stromal invasion and superficial lymphatic invasion (pt1a) 2) dome, right lateral, left lateral and tumor bed: free of tumor. 1) main mass and deep biopsy: papillary, low grade(transitional cell, grade II) with focally superficial lamina propria invasion(pt1a) 2) dome, right lateral and left lateral wall: free of tumor. Urinary bladder, partial cystectomy: 1) mixed (high grade transitional cell and well differentiated adeno). - with invasion in lamina propria(t1) - with no vascular invasion - with no perineural invasion - bladder mucosal margins: involvement of tumor(transitional cell in situ) 2) separately submitted specimen: transitional cell in situ. TaN0M0 ( 0a ) T1aN0M0 ( Ⅰ ) T1aN0M0 ( Ⅰ )

10 13 C 1, 2 m C 3, 4 m C 5, 6 m C 7, 8 m C 9, 10 f 33 papillary papillary adeno mucinous adeno 18 C 11 f 33 non-neoplastic Non-neoplastic from C9,10 Urinary bladder, TURBT: papillary, high grade(transitional cell, grade II) with squamous cell (mixed ) involving muscle proper. T4aN0M0 ( Ⅲ ) Urianry bladder, TURB: 1) main mass and deep biopsy: papillary, low grade (transitional cell grade 2), with superficial stromal invasion (pt1a) 2) dome, right and left lateral wall: free of tumor. Urinary bladder, TURBT and biopsy: 1) dome mass, dome mass-deep biopsy, neck mass, right posteriolateral mass, right posterolateral deep biopsy, left posterolateral main mass, and left posterolateral deep biopsy: papillary, low-grade (transitional cell, grade 2), without stromal invasion (pt20) 2) anterior wall: papillary tumor of low malignant potential(transitional cell, grade 1). 1) mass: papillary, low grade(transitional cell II) without stromal invasion 2) deep biopsy: free of tumor. Urinary bladder and umbilicus, partial cystectomy: 1) mucinous adeno mainly composed of signet ring cells of urachal origin, with penetrating the wall and extending to the serosal surface, and with lymphatic invasion 2) resection margins of bladder: free of tumor 3) lymph node, regional(0/1): free of tumor 4) umbilicus and urachus: Free of tumor without urachal tissue. TaN0M0 ( 0a ) TaN0M0 ( 0a ) T3N0M0 ( Ⅲ )

11 19 D 1, 2 m D 3, 4 m D 5, 6 m D 7, 8 m D 9, 10 m 44 adeno Bladder, TURBT: 1) main mass: mucinous adeno 2) anterior wall: free of tumor 3) right lateral wall:material insufficiency 4) left lateral wall: free of tumor 5) prostate urethra: free of tumor 6) dome: free of tumor 7) trigone: free of tumor. 24 D 11 f 33 non-neoplastic Non-neoplastic from C9,10 1) main mass: Urothelial, high grade (transitional cell, grade III/III), invading lamina propria 2) right lateral wall: free of tumor 3) left lateral wall: von Brunn's nest 4) left lateral: free of tumor 5) deep biopsy:, high grade (transitional cell, grade III/III) 6) dome: free of tumor. 1. Urethra and prostate, TURP:, high grade (transitional cell, grade III) 2. Urinary bladder, dome, biopsy:, high grade. 1. 1) main mass and B. Main mass, deep biopsy: papillary, high grade (transitional cell grade 3) without stromal invasion (Ta) 2) left posterior lateral wall mass: free of tumor 3) small mass of left posterior lateral wall mass : papillary, low grade 4) another mass of left lateral wall mass and left posterior lateral wall, deep biopsy: papillary, high grade (transitional cell, grade 2) without stromal invasion 5) right lateral wall: free of tumor 6) dome: free of tumor 7) left lateral wall: free of tumor 8) posterior urethra and bladder neck: free of tumor 2. Prostate, TURP: benign prostatic hyperplasia. Urinary bladder, prostate, seminal vesicles, radical cystectomy: 1) papillary, high grade (transitional cell, grade III), with superficial lamina invasion without extension into the muscularis mucosa 2) resection margins, separately submitted as bilateral ureters: free of tumor 3) resection margin, urethra: free of tumor 4) prostate gland: free of tumor 5) seminal vesicle, bilateral: free of tumor 6) lymph nodes, right iliac(0/11), left external iliac(0/5) and regional(0/1):(0/17): free of tumor 7) soft tissue, separately submitted as right and left obturator lymph node: free of tumor 8) appendix, appendectomy: no pathological diagnosis. T4aN0M0 ( Ⅲ ) TaN0M0 ( 0a ) T1aN0M0 ( Ⅰ )

12 25 E 1, 2 m 66 Urinary bladder, radical cystectomy: 1) papillary, high grade (transitional cell, grade III), with extension to the muscle proper(pt2) and prostate, with vascular(probably venous) invasion 2) leiomyoma 3) resection margins, ureters and urethra: free of tumor 4) lymph nodes, perivesical(0/1), right obturator(0/7), left obturator (0/3), right external iliac(0/3), left external iliac(0/15), and right common iliac(0/10): Free of tumor metastasis in all 39 nodes 5) appendix, incidental appendectomy: no pathological diagnosis. 6) small intestine: free of tumor. <Additional and revised report> Urinary bladder, radical cystectomy: 1) papillary, high grade (transitional cell, grade III), with extension to the muscle proper(pt2) and prostate, with vascular(probably venous) invasion. 2) post-operative spindle cell nodule. Note: result of immunohistochemistry: Actin(-), Cytokeratin(-), MIB-1(+). T4aN0M0 ( Ⅲ ) 26 E 3, 4 f E 5, 6 m E 7, 8 f E 9, 10 m 44 mucinous adeno adeno urachal adeno papillary, high grade (transitional cell, grade III), with superficial lamina invasion without muscular mucosa(t1a). 1) main mass and deep biopsy: invasive papillary, high grade (transitional cell, grade III), with extension to the proper muscle 2) dome, right and left lateral wall: free of tumor. 1) main mass and deep biopsy: invasive, high grade (transitional cell, grade III), with invasion to the proper muscle layer 2) left lateral wall: chronic nonspecific inflammation without tumor. Urinary bladder, radical cystectomy and appendectomy: 1) urachal mucinous adeno with invasion to the muscle layer but confined to the urachus, stage II by Sheldon system, see note. 2) ileum segmental resection: free of tumor 3) prostate: free of tumor 4) seminal vesicles, both: free of tumor 5) ureters, both: free of tumor 6) vas deferens, both: free of tumor 7) appendix: no pathological diagnosis. 8) regional lymph nodes, perivesical(0/4), common iliac, right(0/8), left(0/4), obturator, right(0/3), left(0/3), left femoral(0/0): (0/22): free of tumor in all 22 lymph nodes. Note: Sheldon staging system: Stage I: cancer is confined to the urachal mucosa Stage II: cancer is invasive but confined to the urachus Stage III: local extension to the bladder(iiia), abdominal wall(iiib), peritoneum(iiic) or visceral other than bladder(iiid) Stage IV: metastasis to regional lymph nodes(iva) or distant sites(ivb). T1aN0M0 ( Ⅰ ) T2N0M0 ( Ⅱ ) T3bN1M0 ( Ⅳ )

13 , high grade(transitional cell, grade III) 30 F 1, 2 f 79 with invasion to the proper muscle layer. T2N0M0 ( Ⅱ ) 31 F 3, 4 f F 5, 6 m F 7, 8 m F 9, 10 m 86 squamous cell Urinary bladder, biopsy: 1) main mass: papillary, high grade(transitional cell grade 3) with superficial laminar invasion 2) deep biopsy: papillary, high grade, with invasion to the muscularis mucosa(pt1b) 3) bladder neck deep biopsy: papillary, low grade, without stromal invasion. Urinary bladder, seminal vesicles and prostate, radical cystectomy: 1) invasive, high grade(transitional cell grade III) with extension to the perivesical fat tissue and with extensive lymphovascular invasion 2) resection margins, ureteral and urethral: free of tumor 3) prostate: free of tumor 4) seminal vesicles, bilateral: free of tumor 5) lymph nodes, right internal iliac(0/2), left internal iliac(0/2), left obturator(0/2) and left external iliac(0/0): free of tumor in all 6 nodes 6) appendix, incidental appendectomy: fatty obliteration. Urinary bladder, ureters, seminal vesicls, prostate gland, raidial cystectomy: 1) urinary bladder: Invasive, high grade, with extension to the perivesical fat tissue. 2) prostate: Adeno (Gleason's score: 3+3:6) involving1 lobe(size:1.0x0.6cm) 3) seminal vesicles, both: free of tumor 4) resection margins, urethra and both ureter: free of tumor 5) lymph nodes, pelvic, dissection: right common iliac(0/7), right external iliac(0/10), right obturator(0/7), left common iliac(0/4), left external iliac(0/5) and left obturoator(0/6):(0/39): free of tumor 6) soft tissue, separately submitted as paraaortic lymph ndoe: fat necrosis. 1) labelled as "mass": poorly differentiated squamous infiltrating diffusely into the fibromuscular wall 2) llabelled as "anterior wall mass": poorly differentiated squamous infiltrating diffusely into the fibromuscular wall. T1bN0M0 ( Ⅰ ) T3bN0M0 ( Ⅲ ) T3bN0M0 ( Ⅲ )

14 35 G 1, 2 m G 3, 4 m G 5, 6 m G 7, 8 m Urinary bladder, prostate, seminal vesicle and ureter, radical mastectomy: diffuse infiltrative, high grade with 1) size: approximately 6x5cm 2) penetration of bladder wall and invasion to prostate and seminal vesicle 3) perineural invasion 4) intact resection margins including right and left ureter 5) no lymph node metastasis (0/54), external iliac right(0/6) and left(0/10), common iliac, right(0/13) and left(0/5), obturator, right(0/15) and left(0/3), perivascular(0/2) 2. Appendix, appendectomy: free from tumor extension. 1) papillary, high grade, with squamous and glandular differentiation and sarcomatoid differentiation, consistent with sarcomatoid 2) urinary bladder, "deep biopsy", TURB: with invasion to the muscle proper and lymphatic invasion. 1) main mass:, high grade 2) left posterior wall mass: with extensive proper muscle invasion 3) dome mass:, high grade 4) not specified specimen: several fragments of proper muscle bundles without evidence of tumor. 1) right lateral wall: -, high grade, with invasion to the muscularis mucosa(pt1b) - in situ 2) right posterolateral wall: papillary, high grade, without stromal invasion 3) right lateral, left lateral and dome: free of tumor. T4aN0M1 ( Ⅳ ) T4N1M1 ( Ⅳ ) T2bN0M0 ( Ⅱ ) T1bN0M0 ( Ⅰ ) 39 G 9, 10 f 69 squamous cell 1), high grade, with squamous differentiation, with invasion to the muscularis mucosa (pt1b) 2) urinary bladder, deep biopsy: with invasion limited in superficial lamina propria 3) urinary bladder, dome, right and left lateral wall, TURB: free from tumor extension. T1bN0M0 ( Ⅰ )

15 40 H 1, 2 m H 3, 4 m H 5, 6 f H 7, 8 f H 9, 10 f I 1, 2 m I 3, 4 m I 5, 6 f I 7, 8 m I 9, 10 m squamous cell in situ in situ Urinary bladder: 1) main mass, TURBT: high-grade with involvement of muscularis propria 2) urinary bladder, deep, biopsy: high-grade 3) urinary bladder, dome, and right lateral wall, biopsy: in-situ 4) urinary bladder, left lateral wall, biopsy: free of tumor. Urinary bladder, TURBT: 1) main mass and deep biopsy: papillary, high grade, with invasion to the proper muscle layer(pt1c) 2) dome: in situ 3) left lateral wall mass: papillary, high grade 4) right and left lateral wall: free of tumor. Urinary bladder, TURBT: 1) main mass and deep biopsy: papillary, high grade, without stromal invasion 2) random, right and left lateral wall: chronic nonspecific inflammation without tumor. T2aN0M0 ( Ⅱ ) T3bN0M0 ( Ⅲ ) Urinary bladder, TURBT:, high grade, focally squamous differentiation, with invasion to the muscularis mucosa(pt1b). T1aN0M0 ( Ⅰ ) Urinary bladder, TURBT: invasive squamous cell, well differentiated, with marked necrosis and extension to the muscle proper and probably to perivesical soft tissue, see note. Note: This tumor is probably metaplastic from previous. But the possibility T2bN0M0 ( Ⅱ ) of metastatic squamous cell of uterine cervix cannot be excluded. Urinary bladder, TURBT: main mass and deep biopsy:, high grade, with invasion to the muscle T2N0M0 ( Ⅱ ) proper(pt2). Urinary bladder, TURBT: posterior wall mass, anterior wall mass, right lateral wall mass, and right side posterior wall mass: TisN0M0 (0is ) 1) papillary, high grade, without stromal invasion 2) in situ. 1) main mass and deep biopsy: papillary, high grade(transitional cell, grade III) with invasion beyond muscularis mucosa but not to the muscle proper (pt1c) 2) dome, right and left lateral walls: free of tumor 3) posterior wall: in situ with Pagetoid spread of. main mass and deep biopsy: 1) papillary, high grade (transitional cell, grade III), with in situ superficial stromal invasion(pt1a) 2) in situ. squamous cell TisN0M0 (0is ) TisN0M0 (0is ) Urinary bladder, TURBT: papillary, high grade(transitional cell, grade II) with squamous cell (mixed ) involving muscle proper. T2N0M0 ( Ⅱ ) comment TURBT : Trans urethral resection of bladder tumor

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT) Bladder Case 1 February 17, 2007 Specimen (s) received: Bladder Tumor Pre-operative Diagnosis: Bladder Cancer Post operative Diagnosis: Bladder Cancer Procedure: Cystoscopy, transurethral resection of

More information

Carcinoma of the Urinary Bladder Histopathology

Carcinoma of the Urinary Bladder Histopathology Carcinoma of the Urinary Bladder Histopathology Reporting Proforma (Radical & Partial Cystectomy, Cystoprostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family

More information

A218 : Esophagus cancer tissues. (formalin fixed)

A218 : Esophagus cancer tissues. (formalin fixed) (formalin fixed) For research use only Specifications: No. of cases: 40 Tissue type: Esophagus cancer tissues No. of spots: 2 spots from each cancer case (80 spots) 4 non-neoplastic spots (4 spots) Total

More information

A patient with recurrent bladder cancer presents with the following history:

A patient with recurrent bladder cancer presents with the following history: MP/H Quiz A patient with recurrent bladder cancer presents with the following history: 9/23/06 TURB 1/12/07 TURB 4/1/07 TURB 7/12/07 TURB 11/14/07 Non-invasive papillary transitional cell carcinoma from

More information

Urinary Bladder, Ureter, and Renal Pelvis

Urinary Bladder, Ureter, and Renal Pelvis Urinary Bladder, Ureter, and Renal Pelvis Protocol applies to all carcinomas of the urinary bladder, ureter, and renal pelvis. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition Procedures

More information

Definition of Synoptic Reporting

Definition of Synoptic Reporting Definition of Synoptic Reporting The CAP has developed this list of specific features that define synoptic reporting formatting: 1. All required cancer data from an applicable cancer protocol that are

More information

The pathology of bladder cancer

The pathology of bladder cancer 1 The pathology of bladder cancer Charles Jameson Introduction Carcinoma of the bladder is the seventh most common cancer worldwide [1]. It comprises 3.2% of all cancers, with an estimated 260 000 new

More information

BLADDER CANCER EPIDEMIOLOGY

BLADDER CANCER EPIDEMIOLOGY BLADDER CANCER WHAT IS NEW AND CLINICALLY RELEVANT Canadian Geese - Geist Reservoir (my backyard), Indianapolis, USA BLADDER CANCER EPIDEMIOLOGY Urinary bladder 17,960 2% Urinary bladder 4,390 1.6% Siegel

More information

A301 VI- Various cancer tissues with corresponding normal tissues

A301 VI- Various cancer tissues with corresponding normal tissues A301 VI- Various cancer tissues with (formalin fixed) For research use only Specifications: No. of cases: 28 Tissue type: Various cancer tissues with No. of spots: 2 spots from each cancer case (56 spots)

More information

UICC TNM 8 th Edition Errata

UICC TNM 8 th Edition Errata UICC TNM 8 th Edition Errata ions are in italics Head and Neck Tumours Pages 20, p27, p34, p38, p41, and p49 ly pn2a Metastasis in a single ipsilateral lymph node, less than 3cm in greatest dimension with

More information

TOPICS FOR DISCUSSION

TOPICS FOR DISCUSSION INTERNATIONAL SOCIETY OF UROLOGIC PATHOLOGY PATHOLOGIC STAGING OF SELECT UROLOGIC MALIGNANCIES Mahul B. Amin, MD Professor and Chairman Pathology and Laboratory Medicine Cedars-Sinai Medical Center Los

More information

A220: Larynx cancer tissues. (formalin fixed)

A220: Larynx cancer tissues. (formalin fixed) A220: Larynx cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Larynx cancer tissues No. of spots: 2 spots from each cancer case (90 spots) 4 non-neoplastic

More information

(formalin fixed) 6 non-neoplastic spots (6 spots) Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm

(formalin fixed) 6 non-neoplastic spots (6 spots) Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm CBA729-Test slide, Head and neck cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 6 Tissue type: Test slide, Head and neck cancer tissues No. of spots: 6 spots from each

More information

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy Prostate Gland Protocol applies to invasive carcinomas of the prostate gland. Protocol web posting date: July 2006 Protocol effective date: April 2007 Based on AJCC/UICC TNM, 6 th edition Procedures Needle

More information

UICC TNM 8 th Edition Errata

UICC TNM 8 th Edition Errata UICC TNM 8 th Edition Errata ions are in italics Page 28 Oropharynx p16 positive Pathological Stage II,T2 N2 M0 T3 N0,N1 M0 Stage II,T2 N2 M0 T3,T4 N0,N1 M0 Page 61 Oesophagus Adenocarcinoma Pathological

More information

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER (Limited text update December 21) M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, J. Palou, M. Rouprêt Eur Urol 211 Apr;59(4):584-94 Introduction

More information

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series Collecting Cancer Data Bladder & Renal Pelvis NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

A916: rectum: adenocarcinoma

A916: rectum: adenocarcinoma General facts of colorectal cancer The colon has cecum, ascending, transverse, descending and sigmoid colon sections. Cancer can start in any of the r sections or in the rectum. The wall of each of these

More information

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Houston Society of Clinical Pathologists 58 th Annual Spring Symposium Houston, TX April 8, 2017 Jesse K. McKenney, MD Classification

More information

Carcinoma of the Renal Pelvis and Ureter Histopathology

Carcinoma of the Renal Pelvis and Ureter Histopathology Carcinoma of the Renal Pelvis and Ureter Histopathology Reporting Proforma (NEPHROURETERECTOMY AND URETERECTOMY) Includes the International Collaboration on Cancer reporting dataset denoted by * Family

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction

More information

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates Staging Challenges in Lower GI Cancers Sanjay Kakar, MD University of California, San Francisco March 05, 2017 Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education

More information

Q&A. Collecting Cancer Data: Bladder. Collecting Cancer Data: Bladder 3/3/2011. NAACCR Webinar Series 1. Agenda

Q&A. Collecting Cancer Data: Bladder. Collecting Cancer Data: Bladder 3/3/2011. NAACCR Webinar Series 1. Agenda Collecting Cancer Data: Bladder March 3, 2011 NAACCR 2010-2011 Webinar Series Agenda Coding Moment Bladder Overview Multiple Primary Histology Rules Collaborative Stage Data Collection System Diagnostic,

More information

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Kidney Case 1 SURGICAL PATHOLOGY REPORT Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which

More information

Urinary Bladder, Ureter, and Renal Pelvis

Urinary Bladder, Ureter, and Renal Pelvis Urinary Bladder, Ureter, and Renal Pelvis Protocol applies to all carcinomas of the urinary bladder, ureter, and renal pelvis. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition Procedures

More information

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018 Prostate cancer staging and datasets: The Nitty-Gritty What determines our pathological reports? Dan Berney Maastricht 2018 Biopsy reporting. How not to do it. The TNM 8 th edition. Changes good and bad

More information

Neoplasms of the Prostate and Bladder

Neoplasms of the Prostate and Bladder Neoplasms of the Prostate and Bladder 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 CDC & Florida DOH Attribution

More information

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 Presentation Outline Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 X:\FCDS_PUB\wwwroot\downloads\Teleconfere nces\2013 FCDS Educational Webcast Series February 28, 2013 General Information

More information

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 X:\FCDS_PUB\wwwroot\downloads\Teleconfere nces\2013 FCDS Educational Webcast Series February 28, 2013 1 Steven Peace, BS, CTR Susan Smith

More information

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding

More information

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition Colon and Rectum Protocol applies to all invasive carcinomas of the colon and rectum. Carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix are excluded. Protocol revision date: January

More information

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles Prostate Cancer Histopathology Reporting Proforma (Radical Prostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth Sex Male

More information

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy. 30 th Congress of the European Society of Pathology Tuesday, September 11, 2018 The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

More information

Patient identifiers Date of request Accession/Laboratory number. TUMOUR FOCALITY (Note 4) (Note 3)

Patient identifiers Date of request Accession/Laboratory number. TUMOUR FOCALITY (Note 4) (Note 3) Carcinoma of the Bladder Histopathology Reporting Guide Cystectomy, Cystoprostatectomy and Diverticulectomy Specimen Family/Last name Given name(s) Date of birth DD MM YYYY Patient identifiers Date of

More information

Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis

Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis 73. Urinary Bladder and Male Pelvis Urinary bladder carcinoma is best locally staged with MRI. It is important however to note that a thickened wall (> 5 mm) is a non-specific finding seen in an underfilled

More information

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Authors: Dr Gordon Armstrong, Dr Sue Pritchard 1. General Comments 1.1 Cancer reporting: Biopsies

More information

A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues

A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding

More information

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition Small Intestine Protocol applies to all invasive carcinomas of the small intestine, including those with focal endocrine differentiation. Excludes carcinoid tumors, lymphomas, and stromal tumors (sarcomas).

More information

BLADDER CANCER: PATIENT INFORMATION

BLADDER CANCER: PATIENT INFORMATION BLADDER CANCER: PATIENT INFORMATION The bladder is the balloon like organ located in the pelvis that stores and empties urine. Urine is produced by the kidneys, is conducted to the bladder by the ureters,

More information

Gastric Cancer Histopathology Reporting Proforma

Gastric Cancer Histopathology Reporting Proforma Gastric Cancer Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given name(s) Date of birth Sex Male Female Intersex/indeterminate

More information

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I. Common Differential Diagnoses in Urological Pathology Jonathan I. Epstein Prostate Adenocarcinoma vs. Urothelial Carcinoma 1 2 NKX3.1 NKX3.1 3 4 5 6 Proposed ISUP Recommendations Option to use PSA as a

More information

4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD

4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD MUSC Pathology Symposium Kiawah Island April 18, 2018 Jesse K. McKenney, MD 1 Urothelial Carcinoma with Alternative Differentiation 2 Urothelial Carcinoma with Alternative Differentiation Recognition as

More information

Imaging in gastric cancer

Imaging in gastric cancer Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.

More information

Etiology and diagnosis of bladder cancer

Etiology and diagnosis of bladder cancer Etiology and diagnosis of bladder cancer Introduction Incidence: the most common urothelial tumor, representing the 2 nd most common urological tumor in men (4 th in overall frequency) and the 1 st in

More information

A103(9)- Normal tissues, more than single spots

A103(9)- Normal tissues, more than single spots A103(9)- Normal tissues, more than single spots (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Normal tissues, more than single spots No. of spots: 2 spots from each

More information

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4). GU Cancer Staging: Updates and Challenging Areas 13 th Current Issues in Surgical Pathology San Francisco, CA June 5, 2010 Jeffry P. Simko, PhD, MD Associate Professor Departments of Urology and Anatomic

More information

Quiz. b. 4 High grade c. 9 Unknown

Quiz. b. 4 High grade c. 9 Unknown Quiz 1. 10/11/12 CT scan abdomen/pelvis: Metastatic liver disease with probable primary colon malignancy. 10/17/12 Colonoscopy with polypectomy: Adenocarcinoma of sigmoid colon measuring at least 6 mm

More information

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES Prostate Cancer Histopathology Reporting Proforma (Radical Prostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth Indigenous

More information

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix. Uterine Cervix Protocol applies to all invasive carcinomas of the cervix. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition and FIGO 2001 Annual Report Procedures Cytology (No Accompanying

More information

5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney.

5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney. Bladder Case Scenario 1 History 5/23/16: A 52-year-old male, smoker was admitted to our hospital with a 3-month history of right pelvic pain, multiple episodes of gross hematuria, dysuria, and extreme

More information

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation. Prostate t Cancer MR Report Disclosure Information Vikas Kundra, M.D, Ph.D. I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a g product

More information

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases. Case Scenario 1 3/8/13 H&P 68 YR W/M presents w/elevated PSA. Patient is a non-smoker, current alcohol use. Physical Exam: On digital rectal exam the sphincter tone is normal and there is a 1 cm nodule

More information

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Case 1 72 year old white female presents with a nodular thyroid. This was biopsied in

More information

Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland

Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland Version: Protocol Posting Date: June 2017 Includes ptnm requirements from the 8 th Edition, AJCC Staging Manual

More information

Staging and reporting of urothelial carcinoma of the urinary bladder

Staging and reporting of urothelial carcinoma of the urinary bladder & 2009 USCAP, Inc All rights reserved 0893-3952/09 $32.00 www.modernpathology.org Staging and reporting of urothelial carcinoma of the urinary bladder Liang Cheng 1,2, Rodolfo Montironi 3, Darrell D Davidson

More information

SEER Summary Stage Still Here!

SEER Summary Stage Still Here! SEER Summary Stage Still Here! CCRA NORTHERN REGION STAGING SYMPOSIUM SEPTEMBER 20, 2017 SEER Summary Stage Timeframe: includes all information available through completion of surgery(ies) in the first

More information

Pathologic Assessment of Invasion in TUR Specimens. A. Lopez-Beltran. T1 (ct1)

Pathologic Assessment of Invasion in TUR Specimens. A. Lopez-Beltran. T1 (ct1) Pathologic Assessment of Invasion in TUR Specimens A. Lopez-Beltran T1 (ct1) 1 Prognostic factors for progression/invasive disease Ta,T1,CIS- NMIBC :TNM 2017 ESSENTIAL: Grade T stage CIS Number of lesions

More information

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017 Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017 Dr Puay Hoon Tan Division of Pathology Singapore General Hospital Prostate cancer (acinar adenocarcinoma) Invasive carcinoma composed

More information

VULVAR CARCINOMA. Page 1 of 5

VULVAR CARCINOMA. Page 1 of 5 VULVAR CARCINOMA EXAMPLE OF A VULVAR CARCINOMA USING PROPOSED TEMPLATE Case: Invasive squamous cell carcinoma arising in D-VIN Tumor in left labia major Left partial vaginectomy and sentinel lymph node

More information

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised. Case Scenario 1 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of

More information

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017 Update on staging colorectal carcinoma, the 8 th edition AJCC Dale C. Snover, MD November 3, 2017 General overview of staging Reason for uniform staging Requirements to use AJCC manual and/or CAP protocols

More information

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised. Case Scenario 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of alcohol.

More information

Jesse K. McKenney, MD

Jesse K. McKenney, MD Jesse K. McKenney, MD Outline Microscopic anatomy of the urinary bladder Diagnosing invasion Subtle patterns (variants) of carcinoma Clinically important variants of carcinoma Microanatomy of Bladder Initial

More information

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank Quiz 1 Overview 1. Beginning with the cecum, which is the correct sequence of colon subsites? a. Cecum, ascending, splenic flexure, transverse, hepatic flexure, descending, sigmoid. b. Cecum, ascending,

More information

Protocol for the Examination of Cystectomy Specimens From Patients With Carcinoma of the Urinary Bladder

Protocol for the Examination of Cystectomy Specimens From Patients With Carcinoma of the Urinary Bladder Protocol for the Examination of Cystectomy Specimens From Patients With Carcinoma of the Urinary Bladder Version: UrinaryBladder 4.0.1.1 Protocol Posting Date: February 2019 CAP Laboratory Accreditation

More information

Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016

Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016 BLADDER CANCER Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016 BLADDER CANCER = UROTHELIAL CANCER Antiquated term is Transitional Cell Carcinoma

More information

Melanoma Case Scenario 1

Melanoma Case Scenario 1 Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5

More information

OSCaR Update. Manager s Update. Upcoming Events. Donald Shipley, MS

OSCaR Update. Manager s Update. Upcoming Events. Donald Shipley, MS Volume 8, Quarter 1 Winter 2007 Oregon State Cancer Registry OSCaR Update In this Issue: Update on New MPH Rules Bladder Cancer Incidence and Mortality Focus on Abstracting, Coding, and Staging Bladder

More information

Urology An introduction to cut up DR J R GOEPEL

Urology An introduction to cut up DR J R GOEPEL Urology An introduction to cut up DR J R GOEPEL Overview Principles Individual organs Small pieces Partial resections Whole organs Data recording and data sets Principles You are working for the patient

More information

25 TH ICRO DEHRADUN STAGING OF GENITOURINARY MALIGNANCIES

25 TH ICRO DEHRADUN STAGING OF GENITOURINARY MALIGNANCIES 25 TH ICRO DEHRADUN STAGING OF GENITOURINARY MALIGNANCIES SPEAKER DR DEEPAK ABROL CLINICAL ONCOLOGIST JAND K HEALTH SERVICES CONSULTANT ONCOLOGIST MAHARISHI DAYANAND HOSPITAL AND MEDICAL RESEARCH CENTER

More information

Melanoma Case Scenario 1

Melanoma Case Scenario 1 Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5

More information

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital. Male genital tract tumors Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital. adenocarcinoma Prostate Cancer most common male cancer in western countries more detected in

More information

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with

More information

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of Tiền liệt tuyến Tiền liệt tuyến Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of solid and microcystic areas.

More information

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder Version: Protocol Posting Date: June 2017 Includes ptnm requirements from the 8 th Edition, AJCC Staging Manual

More information

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase Case 1 67 year old male presented with gross hematuria H/o acute prostatitis & BPH Urethroscopy: small, polypoid growth with a broad base emanating from the left side of the verumontanum Serum PSA :7 ng/ml

More information

Bladder Case # 1. Principal Diagnosis: Bladder Tumor, Suspect Transitional Cell Carcinoma. Secondary Diagnoses: 1. Hypertension. 2. Hyperlipidemia.

Bladder Case # 1. Principal Diagnosis: Bladder Tumor, Suspect Transitional Cell Carcinoma. Secondary Diagnoses: 1. Hypertension. 2. Hyperlipidemia. DISCHARGE SUMMARY Bladder Case # 1 Date: 04/22/2010 Principal Diagnosis: Bladder Tumor, Suspect Transitional Cell Carcinoma. Secondary Diagnoses: 1. Hypertension. 2. Hyperlipidemia. Hospital Course: Mr.

More information

11/21/13 CEA: 1.7 WNL

11/21/13 CEA: 1.7 WNL Case Scenario 1 A 70 year-old white male presented to his primary care physician with a recent history of rectal bleeding. He was referred for imaging and a colonoscopy and was found to have adenocarcinoma.

More information

Protocol for the Examination of Specimens from Patients with Carcinoma of the Urinary Bladder

Protocol for the Examination of Specimens from Patients with Carcinoma of the Urinary Bladder Protocol for the Examination of Specimens from Patients with Carcinoma of the Urinary Bladder Protocol applies primarily to invasive and noninvasive carcinomas, including carcinoma in situ. Version: Protocol

More information

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY Colorectal Cancer Structured Pathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.03). Family name Given name(s) Date of birth DD MM YYYY S1.02 Clinical details

More information

Multiple Primary and Histology Site Specific Coding Rules URINARY. FLORIDA CANCER DATA SYSTEM MPH Urinary Site Specific Coding Rules

Multiple Primary and Histology Site Specific Coding Rules URINARY. FLORIDA CANCER DATA SYSTEM MPH Urinary Site Specific Coding Rules Multiple Primary and Histology Site Specific Coding Rules URINARY 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways to view the Multiple l Primary/Histology

More information

Case Presentation 58 year old male with recent history of hematuria, for which he underwent cystoscopy. A 1.5 cm papillary tumor was found in the left lateral wall of the bladder. Pictures of case Case

More information

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Anatomic Pathology / CYTOKERATINS 7 AND 20 IN PROSTATE AND BLADDER CARCINOMAS Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Nader H. Bassily,

More information

Synonyms. Nephrogenic metaplasia Mesonephric adenoma

Synonyms. Nephrogenic metaplasia Mesonephric adenoma Nephrogenic Adenoma Synonyms Nephrogenic metaplasia Mesonephric adenoma Definition Benign epithelial lesion of urinary tract with tubular, glandular, papillary growth pattern Most frequently in the urinary

More information

Staging and Grading Last Updated Friday, 14 November 2008

Staging and Grading Last Updated Friday, 14 November 2008 Staging and Grading Last Updated Friday, 14 November 2008 There is a staging graph below Blood in the urine is the most common indication that something is wrong. Often one will experience pain or difficulty

More information

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urethra and Periurethral Glands

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urethra and Periurethral Glands Protocol for the Examination of Specimens From Patients With Carcinoma of the Urethra and Periurethral Glands Version: Protocol Posting Date: June 2017 Includes ptnm requirements from the 8 th Edition,

More information

3. Guidelines for Reporting Bladder Cancer, Prostate Cancer and Renal Tumours

3. Guidelines for Reporting Bladder Cancer, Prostate Cancer and Renal Tumours 60 3. Guidelines for Reporting Bladder Cancer, Prostate Cancer and Renal Tumours Compilation and editing and of this volume: Prof. Chandu de Silva (Consultant Histopathologist) List of contributors Consultant

More information

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ). SOLID TUMORS WORKSHOP Cases for review Prostate Cancer Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ). January 2009 PSA 4.4, 20% free; August 2009 PSA 5.2; Sept 2009

More information

Collection of Recorded Radiotherapy Seminars

Collection of Recorded Radiotherapy Seminars IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org Conservative Treatment of Invasive Bladder Cancer Luis Souhami, MD Professor Department of Radiation Oncology

More information

Case Scenario 1: Breast

Case Scenario 1: Breast Case Scenario 1: Breast A 63 year old white female presents with a large mass in her left breast. 4/15/13 Mammogram/US: 1. Left breast mammographic and sonographic at 3:00 measuring 7.1 cm highly suggestive

More information

Pathology Reports in Underwriting

Pathology Reports in Underwriting UFS Pathology Reports in Underwriting NEHOUA, 2012 Steven J. Rigatti, MD Senior Medical Director, MetLife Path Reports - Importance Microscopic examination of cells and tissue is the gold standard for

More information

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology: Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 A 74 year old male with a history of GERD presents complaining of dysphagia. An esophagogastroduodenoscopy

More information

CPC on Cervical Pathology

CPC on Cervical Pathology CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Cervical Smear: High Grade SIL (CIN III) Cervical Smear: High Grade

More information

Protocol applies to melanoma of cutaneous surfaces only.

Protocol applies to melanoma of cutaneous surfaces only. Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Procedures Biopsy (No Accompanying Checklist) Excision Re-excision Protocol revision date: January 2005 Based on AJCC/UICC

More information

Large blocks in prostate and bladder pathology

Large blocks in prostate and bladder pathology Large blocks in prostate and bladder pathology Farkas Sükösd Department of Pathology, University of Szeged The history of the large block technique in radical prostatectomy and cystectomy The first large

More information

EAU MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

EAU MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER EAU MUSLE-INVASIVE AND METASTATI LADDER ANER (Limited text update March 2016) J.A. Witjes (hair), E. ompérat, N.. owan, M. De Santis, G. Gakis, N. James, T. Lebret, A.G. van der Heijden, M.J. Ribal Guidelines

More information

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on? MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion

More information